Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study-A study of the Dutch Head and Neck Society

被引：0
|
作者：
Driessen, Chantal
De Boer, J. P.
Gelderblom, Hans
Rasch, Coen R. N.
de Jong, Martin
Verbist, Berit M.
Tesselaar, Margot Et
Van der Graaf, Winette T. A.
Kaanders, J. H.
Van Herpen, Carla M. L. -
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and toxicity of docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy followed by two schedules cisplatin-containing concomitant chemoradiotherapy (CRT) in patients with locally advanced head and neck cancer (LAHNC): The CONDOR study
    Driessen, C. M. L.
    De Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    De Jong, M. A.
    Verbist, B. M.
    Tesselaar, M. E. T.
    Van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    Van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S749 - S749
  • [2] Quality of life of patients with locally advanced head and neck cancer (LAHNC) treated with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing chemoradiotherapy (CRT).
    Driessen, Chantal
    Groenewoud, Hans
    De Boer, J. P.
    Gelderblom, Hans
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    L-Van Herpen, Carla M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
    Driessen, C. M. L.
    de Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    de Jong, M. A.
    Verbist, B. M.
    Melchers, W. J. G.
    Tesselaar, M. E. T.
    van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 52 : 77 - 84
  • [4] Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
    Paccagnella, A.
    Ghi, M. G.
    Loreggian, L.
    Buffoli, A.
    Koussis, H.
    Mione, C. A.
    Bonetti, A.
    Campostrini, F.
    Gardani, G.
    Ardizzoia, A.
    Dondi, D.
    Guaraldi, M.
    Cavallo, R.
    Tomio, L.
    Gava, A.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1515 - 1522
  • [5] Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
    Driessen, Chantal M. L.
    Groenewoud, Johannes M. M.
    de Boer, Jan Paul
    Gelderblom, Hans
    van der Graaf, Winette T. A.
    Prins, Judith B.
    Kaanders, Johannes H. A. M.
    van Herpen, Carla M. L.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1233 - 1242
  • [6] Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
    Chantal M. L. Driessen
    Johannes M. M. Groenewoud
    Jan Paul de Boer
    Hans Gelderblom
    Winette T. A. van der Graaf
    Judith B. Prins
    Johannes H. A. M. Kaanders
    Carla M. L. van Herpen
    Supportive Care in Cancer, 2018, 26 : 1233 - 1242
  • [7] Ototoxicity in locally advanced head and neck cancer (LAHNC) patients (pts) treated with induction chemotherapy (IC) followed by cisplatin-based chemoradiotherapy (CRT)
    Driessen, C.
    Snik, A.
    Leijendeckers, J.
    de Boer, J. P.
    Gelderblom, H.
    van Opstal, C.
    van der Graaf, W.
    Kaanders, J.
    van Herpen, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer
    Janinis, J
    Papadakou, M
    Panagos, G
    Panousaki, A
    Georgoulias, V
    Hatzidaki, D
    Lefantzis, D
    Dokianakis, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 227 - 231
  • [9] Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC).
    Hitt, R.
    Grau, J.
    Lopez-Pousa, A.
    Berrocal, A.
    Garcia-Giron, C.
    Belon, J.
    Sastre, J.
    Martinez-Trufero, J.
    Cortes-Funes, H.
    Cruz-Hernandez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 283S - 283S
  • [10] Preliminary results of a pilot study with a modified induction docetaxel/cisplatin/5-FU (TPF) followed by concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC)
    Serrano, S.
    Martinez-Trufero, J.
    Miguelsanz, S.
    Yubero, A.
    Lastra, R.
    Polo, E.
    Lambea, J.
    Segui, M. A.
    Pujol, E.
    Isla, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 476 - 477
12345